Clinical trials
Observational Lung Neoplasms trials in South Korea
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
42 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2009 | 2 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 2 |
| 2013 | 4 |
| 2014 | 1 |
| 2015 | 2 |
| 2016 | 3 |
| 2017 | 2 |
| 2018 | 3 |
| 2020 | 3 |
| 2021 | 5 |
| 2022 | 2 |
| 2023 | 3 |
| 2024 | 2 |
| 2025 | 2 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 18 |
| Completed | 11 |
| Recruiting | 7 |
| Active, not recruiting | 2 |
| Not yet recruiting | 2 |
| Terminated | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Samsung Medical Center | 9 |
| Seoul National University Hospital | 7 |
| Asan Medical Center | 3 |
| Korea University Guro Hospital | 3 |
| National Cancer Center, Korea | 2 |
| Seoul National University Bundang Hospital | 2 |
| Ulsan University Hospital | 2 |
| Yonsei University | 2 |
| AstraZeneca | 1 |
| Chonbuk National University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lung Neoplasms | 42 |
| Disease | 5 |
| Carcinoma, Non-Small-Cell Lung | 3 |
| Pulmonary Disease, Chronic Obstructive | 3 |
| Bronchiectasis | 2 |
| Esophageal Neoplasms | 2 |
| Pancreatic Neoplasms | 2 |
| Pneumothorax | 2 |
| Stomach Neoplasms | 2 |
| Adenocarcinoma of Lung | 1 |
Trials
Showing 1 to 25 of 42. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.